Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First-in-human Prospective Study to Assess the Safety and Efficacy of the CEM-Cage and CEM-Plate

NCT04883411 is registered in ClinicalTrials.gov with ReVivo Medical, Corp. as lead sponsor.

NCT NCT04883411
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04883411 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First-in-human Prospective Study to Assess the Safety and Efficacy of the CEM-Cage and CEM-Plate
Lead sponsor
ReVivo Medical, Corp.
Phase
Not applicable
Overall status
Recruiting
Start date
March 7, 2022
Completion date
December 31, 2027
Enrollment
50 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

intervertebral disc disorder cervical, neck pain, spondylosis, spondylosis with myelopathy, spondylosis with radiculopathy, spondylosis with radiculopathy cervical region